Restoring function in exhausted CD8 T cells during chronic viral infection

被引:3226
作者
Barber, DL
Wherry, EJ
Masopust, D
Zhu, BG
Allison, JP
Sharpe, AH
Freeman, GJ
Ahmed, R [1 ]
机构
[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[3] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA
[4] Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA
[5] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Dept Med, New York, NY 10021 USA
[6] Brigham & Womens Hosp, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature04444
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Functional impairment of antigen-specific T cells is a defining characteristic of many chronic infections, but the underlying mechanisms of T-cell dysfunction are not well understood. To address this question, we analysed genes expressed in functionally impaired virus-specific CD8 T cells present in mice chronically infected with lymphocytic choriomeningitis virus ( LCMV), and compared these with the gene profile of functional memory CD8 T cells. Here we report that PD-1 ( programmed death 1; also known as Pdcd1) was selectively upregulated by the exhausted T cells, and that in vivo administration of antibodies that blocked the interaction of this inhibitory receptor with its ligand, PD-L1 ( also known as B7-H1), enhanced T-cell responses. Notably, we found that even in persistently infected mice that were lacking CD4 T-cell help, blockade of the PD-1/PD-L1 inhibitory pathway had a beneficial effect on the 'helpless' CD8 T cells, restoring their ability to undergo proliferation, secrete cytokines, kill infected cells and decrease viral load. Blockade of the CTLA-4 ( cytotoxic T-lymphocyte-associated protein 4) inhibitory pathway had no effect on either T-cell function or viral control. These studies identify a specific mechanism of T-cell exhaustion and define a potentially effective immunological strategy for the treatment of chronic viral infections.
引用
收藏
页码:682 / 687
页数:6
相关论文
共 30 条
[1]   Therapeutic Vaccines for chronic infections [J].
Autran, B ;
Carcelain, G ;
Combadiere, B ;
Debre, P .
SCIENCE, 2004, 305 (5681) :205-208
[2]   Helping the CD8+ T-cell response [J].
Bevan, MJ .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (08) :595-602
[3]   Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity [J].
Chen, LP .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (05) :336-347
[4]  
Dong HD, 1999, NAT MED, V5, P1365
[5]   Adoptive-cell-transfer therapy for the treatment of patients with cancer [J].
Dudley, ME ;
Rosenberg, SA .
NATURE REVIEWS CANCER, 2003, 3 (09) :666-U2
[6]   CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[7]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[8]   Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I peptide complexes [J].
Gallimore, A ;
Glithero, A ;
Godkin, A ;
Tissot, AC ;
Plückthun, A ;
Elliott, T ;
Hengartner, H ;
Zinkernagel, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1383-1393
[9]   INDUCED EXPRESSION OF PD-1, A NOVEL MEMBER OF THE IMMUNOGLOBULIN GENE SUPERFAMILY, UPON PROGRAMMED CELL-DEATH [J].
ISHIDA, Y ;
AGATA, Y ;
SHIBAHARA, K ;
HONJO, T .
EMBO JOURNAL, 1992, 11 (11) :3887-3895
[10]   Oscillating CD8+ T cell effector functions after antigen recognition in the liver [J].
Isogawa, M ;
Furuichi, Y ;
Chisari, FV .
IMMUNITY, 2005, 23 (01) :53-63